This is an open label multi-center study with the aim of evaluating the efficacy of adipose tissue processed with the SyntrFuge™ system in facial aesthetics and contouring. Patients will be enrolled to the treatment group with adipose tissue processed with the SyntrFuge™ system followed by an injection of autologous microsized adipose tissue in the treatment sites.
Subjects aged of 18-70 years old
Willing and able to read and sign the informed consent and other study materials
Written informed consent has been obtained prior to any study-related procedures
Subjects are ambulatory
Subjects without decisional capacity
Subjects unable to give informed, written consent
Subjects with active infection (redness, swelling, pain, suppuration)
Subjects with any uncontrolled systemic disease
Single group
SyntrFuge System
DeviceMicrosized Adipose Tissue
FaceQ Satisfaction surveys
Change from baseline in FACE-Q Satisfaction with questionnaire score for the treated regions
Global Aesthetic Improvement Scale (GAIS)
Change in facial regions characteristics as measured by the Global Aesthetic Improvement Scale (GAIS) form from baseline
Investigator's Satisfaction Scale
Change in facial regions characteristics as measured by the Investigator's Satisfaction Scale form from baseline
Click on the lead sponsor to view all of their trials.
This trial is not recruiting at the moment. You can still explore other options:
